- Home
- / Aspen Pharmacare
Aspen Pharmacare
Stock Price
$10.3
2024-10-29
Market Capitalization
$4.6 B
2024-10-29
Revenue
R38.9 B
FY, 2019
Aspen Pharmacare Summary
Company Summary
- Overview
- Aspen Pharmacare is a global supplier of branded and generic pharmaceutical products. The company primarily sells therapeutic oils, rubs, and ointments.
- Type
- Public
- Status
- Active
- Founded
- 1850
- HQ
- Durban, ZA | view all locations
- Website
- http://www.aspenpharma.com
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
Key People
Gus Attridge, Executive Director; Deputy Group Chief Executive
Kuseni Dlamini, Independent Non-Executive, Chairman
Lorraine Hill, Group Operating Officer and Responsible Pharmacist
Operating MetricsView all
Countries
150
FY, 2019
Products Launched (Sub-Saharan Africa)
22
120.0%
FY, 2019
Manufacturing Facilities
25
FY, 2018
LocationsView all
66 locations detected
Durban, KZN HQ
South Africa
Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive
Bridgewater Township, NJ
United States
1200 Route 22 East, Suite 2000
Des Plaines, IL
United States
2136 South Wolf Road,
Sioux City, IA
United States
5500 Bradley Street
Haedo, Provincia de Buenos Aires
Argentina
Tres Arroyos 329 Parque Ind. La Cantabrica U.F.46
Melbourne, VIC
Australia
300 Frankston-Dandenong Rd
Aspen Pharmacare Financials
Summary Financials
- Revenue (FY, 2019)
- R38.9B
- Gross profit (FY, 2019)
- R19.7B
- Net income (FY, 2019)
- R2.0B
- Cash (FY, 2019)
- R9.0B
- EBIT (FY, 2019)
- R4.6B
- Enterprise value
- $43.6B